Moffitt Cancer Center’s clinical trials program includes numerous breast cancer research opportunities, including several options for patients with recurrent and late-stage tumors. Located just a short drive away from St. Petersburg, Florida, we are home to one of the area’s most robust clinical research programs. By taking each patient’s unique diagnosis and treatment history into account, the experienced oncologists in The Don and Erika Wallace Comprehensive Breast Program can match patients with the most promising opportunities for their unique needs.
At Moffitt, our status as a National Cancer Institute-designated Comprehensive Cancer Center recognizes our substantial contributions to the advancement of breast cancer treatment. For patients, the advantages are numerous. For instance, Moffitt’s patients can benefit from:
- Individualized therapies that are based on the unique molecular characteristics of a tumor
- Novel therapies, such as newly discovered medications and hormone therapies, before those options are widely available in other settings
- The expertise of clinical oncologists, as well as our behind-the-scenes research and innovation specialists
Moffitt welcomes individuals from St. Petersburg and all surrounding areas to consider our clinical trials. With a caring and knowledgeable team available to help arrange the logistics of clinical trial visits, we make it easy for patients to access the world-class treatments they deserve. And, to eliminate yet another potential barrier, we do not require physician referrals.
To learn more about the breast cancer clinical trials at Moffitt Cancer Center, call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form. Our oncologists treat patients from St. Petersburg, FL, and all surrounding areas.